Clinical trial
Rapamycin (Sirolimus) Treatment for Amyotrophic Lateral Sclerosis
NCT03359538 is registered in ClinicalTrials.gov with Azienda Ospedaliero-Universitaria di Modena as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Rapamycin (Sirolimus) Treatment for Amyotrophic Lateral Sclerosis
- Lead sponsor
- Azienda Ospedaliero-Universitaria di Modena
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- September 19, 2017
- Completion date
- February 15, 2022
- Enrollment
- 63 (actual)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.